RE: Share Price - Crunching the numbers13 Mar 2021 13:46
You can value this in so many different ways.
Let’s be pessimistic. Ignore money in the bank and value this based on a future generation of £40 million a year ebitda.
40/76 million shares = 52 p earnings
So that would put us on a current pe of 12 which is probably fair value for a diagnostic company trading between 10-20 pe. So being pessimistic we could expand the pe to 20 and see £10.20 per share.
Being optimistic, add on aquisitions, growth, a pe north of 20..... valuation could be well north of £15 but without some developments how can the market value it .